These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15780623)

  • 1. Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome.
    Momose I; Umezawa Y; Hirosawa S; Iinuma H; Ikeda D
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1867-71. PubMed ID: 15780623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and activity of tyropeptin A derivatives as potent and selective inhibitors of mammalian 20S proteasome.
    Momose I; Umezawa Y; Hirosawa S; Iijima M; Iinuma H; Ikeda D
    Biosci Biotechnol Biochem; 2005 Sep; 69(9):1733-42. PubMed ID: 16195592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyropeptins A and B, new proteasome inhibitors produced by Kitasatospora sp. MK993-dF2. I. Taxonomy, isolation, physico-chemical properties and biological activities.
    Momose I; Sekizawa R; Hashizume H; Kinoshita N; Homma Y; Hamada M; Iinuma H; Takeuchi T
    J Antibiot (Tokyo); 2001 Dec; 54(12):997-1003. PubMed ID: 11858671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel beta-lactam derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
    Imbach P; Lang M; García-Echeverría C; Guagnano V; Noorani M; Roesel J; Bitsch F; Rihs G; Furet P
    Bioorg Med Chem Lett; 2007 Jan; 17(2):358-62. PubMed ID: 17095212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of boronic acid derivatives of tyropeptin: proteasome inhibitors.
    Watanabe T; Momose I; Abe M; Abe H; Sawa R; Umezawa Y; Ikeda D; Takahashi Y; Akamatsu Y
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2343-5. PubMed ID: 19307118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of proteasome activity by tyropeptin A in PC12 cells.
    Momose I; Sekizawa R; Iinuma H; Takeuchi T
    Biosci Biotechnol Biochem; 2002 Oct; 66(10):2256-8. PubMed ID: 12450145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes.
    Loidl G; Groll M; Musiol HJ; Ditzel L; Huber R; Moroder L
    Chem Biol; 1999 Apr; 6(4):197-204. PubMed ID: 10099130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyropeptins, proteasome inhibitors produced by Kitasatospora sp. MK993-dF2.
    Momose I; Watanabe T
    J Antibiot (Tokyo); 2017 May; 70(5):542-550. PubMed ID: 28196975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship of boronic acid derivatives of tyropeptin: proteasome inhibitors.
    Watanabe T; Abe H; Momose I; Takahashi Y; Ikeda D; Akamatsu Y
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5839-42. PubMed ID: 20727746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome inhibitors; synthesis and activity of arecoline oxide tripeptide derivatives.
    Marastoni M; McDonald J; Baldisserotto A; Canella A; De Risi C; Pollini GP; Tomatis R
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1965-8. PubMed ID: 15050638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, biological evaluation, and structure-activity relationship (SAR) discussion of dipeptidyl boronate proteasome inhibitors, part I: comprehensive understanding of the SAR of alpha-amino acid boronates.
    Zhu Y; Zhao X; Zhu X; Wu G; Li Y; Ma Y; Yuan Y; Yang J; Hu Y; Ai L; Gao Q
    J Med Chem; 2009 Jul; 52(14):4192-9. PubMed ID: 19537716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based optimisation of 2-aminobenzylstatine derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
    Furet P; Imbach P; Fuerst P; Lang M; Noorani M; Zimmermann J; García-Echeverría C
    Bioorg Med Chem Lett; 2002 May; 12(10):1331-4. PubMed ID: 11992770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of boron peptide analogues of Belactosin C as proteasome inhibitors.
    Nakamura H; Watanabe M; Ban HS; Nabeyama W; Asai A
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3220-4. PubMed ID: 19428245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyropeptins A and B, new proteasome inhibitors produced by Kitasatospora sp. MK993-dF2. II. Structure determination and synthesis.
    Momose I; Sekizawa R; Hirosawa S; Ikeda D; Naganawa H; Iinuma H; Takeuchi T
    J Antibiot (Tokyo); 2001 Dec; 54(12):1004-12. PubMed ID: 11858653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors.
    Rydzewski RM; Burrill L; Mendonca R; Palmer JT; Rice M; Tahilramani R; Bass KE; Leung L; Gjerstad E; Janc JW; Pan L
    J Med Chem; 2006 May; 49(10):2953-68. PubMed ID: 16686537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047).
    Zhou HJ; Aujay MA; Bennett MK; Dajee M; Demo SD; Fang Y; Ho MN; Jiang J; Kirk CJ; Laidig GJ; Lewis ER; Lu Y; Muchamuel T; Parlati F; Ring E; Shenk KD; Shields J; Shwonek PJ; Stanton T; Sun CM; Sylvain C; Woo TM; Yang J
    J Med Chem; 2009 May; 52(9):3028-38. PubMed ID: 19348473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of lipopeptides for inhibiting 20S proteasomes.
    Basse N; Papapostolou D; Pagano M; Reboud-Ravaux M; Bernard E; Felten AS; Vanderesse R
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3277-81. PubMed ID: 16630721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leaving groups prolong the duration of 20S proteasome inhibition and enhance the potency of salinosporamides.
    Manam RR; McArthur KA; Chao TH; Weiss J; Ali JA; Palombella VJ; Groll M; Lloyd GK; Palladino MA; Neuteboom ST; Macherla VR; Potts BC
    J Med Chem; 2008 Nov; 51(21):6711-24. PubMed ID: 18939815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome.
    García-Echeverría C; Imbach P; France D; Fürst P; Lang M; Noorani AM; Scholz D; Zimmermann J; Furet P
    Bioorg Med Chem Lett; 2001 May; 11(10):1317-9. PubMed ID: 11392545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling of the binding mode of a non-covalent inhibitor of the 20S proteasome. Application to structure-based analogue design.
    Furet P; Imbach P; Fürst P; Lang M; Noorani M; Zimmermann J; García-Echeverria C
    Bioorg Med Chem Lett; 2001 May; 11(10):1321-4. PubMed ID: 11392546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.